Skip to main navigation Skip to search Skip to main content

Long-term safety and efficacy of semaglutide s.c. once-weekly on weight management in children and adolescents (aged 6 to <18 years) with obesity or overweight

Project: Research

Project Details

StatusActive
Effective start/end date05/18/23 → 05/17/27

Funding

  • Novo Nordisk Incorporated: $98,805.82